The global biorational market is estimated to be worth $x million by 2020, according to a Visiongain analysis. In the forecast period, increasing integrated pesticide management will guide the industry’s growth. In agricultural and terrestrial ecosystems, adverse effects of synthetic pesticides on beneficial organisms have provided ample scope for biological products.
Gain in-depth understanding about the underlying factors driving demand for different Biorationals segments in the top spending countries across the world and identify the opportunities offered by each of them.
In order to develop biochemical sites present only in the target arthropods and not in non-target organismes, efforts were made to create biorational insecticides with selective properties. New insecticides are not immune to development of insect pest resistance and several insecticide resistance cases have been reported since their registration, but various modes have been developed to manage insect pesticide resistance. As most biorational insecticides have demonstrated their effectiveness against various strains of resistant insect species without proof of cross-resistance, they are an important component of IRM strategies. In insect management tactics, bio-national insecticides are promising alternatives. However, toxicity, efficacy, impacts on the environment, and costs must be assessed for each compound. Everyone could consult the local extension agent for information concerning te before using these biologicals.
Which regulations will be most helpful for stakeholders to boost their supply chain network in the global Biorationals market?
Registrants should obtain clearance from the Expert Committee before registration of the products in accordance with a philosophy and approach to the biorational pesticides regulations. It should be recognised that such pesticides differ inherently from conventional pesticides in the regulation of biorational pesticides that many classes of biological controls pose lower potential risks than conventional pesticides. Target species specificity, usually non-toxic method of action and natural occurrence of biosubstances constitute the main differences between biorational pesticides and conventional pesticides. These factors underpin expectations that many classes of biorational pesticide control agents present a lower potential risk than standard pesticides and support the method of testing required for manufacturing product registration.
Enhance your market understanding, including in terms of demand drivers, trends in the industry and the latest technological developments
These compounds have achieved a number of desired pest management targets and currently higher government requirements. These products are highly selective, targeted pest-only, do not persist normally in the environment, handle and apply safer than most chemical pesticides, and tend to protect beneficial organisms. Most biorational insecticides have various modes of action, work against different strains of resistance species, are not cross-resistant, helped to manage insect resistance, and may play an important role in IRM. In the insect nervous system, the majority of biorational pesticides in specific areas are nervous poisons. Some insecticides are acting in a similar manner to ancient nerve poisons that cause collapse, rapid poisoning, lack of coordination, paralysis and death. The other insecticides affect specific systems, such as the molting processes, metamorphosis and the insect endocrinology system. All the biorational or low risk insecticides have relatively low detrimental effect on the environment and its inhabitants, and have little or no adverse consequence for non-target organisms, thus rendering them among important components in IPM program
Which regions might see the demand maturing in certain segments of Biorationals market in near future?
The global biorational market was dominated by North America in 2019, and over the forecast period the area is expected to have a CAGR of more than 11.5%. In this area, a strong regulatory framework has greatly contributed to product penetration against synthetic pesticides. Food processors and farmer companies are taking various agri-business initiatives to address growing food safety concerns. Investments are expected to be driven to boost crop yield rates with minimum environmental effects, especially at the US and Canada, by ongoing food system industrialisation.
Increasing demand from Mexico, India and China for low prices and high quality organic commodities has called for crop producers to improve productivity and minimise pest losses. This has prompted several agro-producers to adopt bio-conductivities to improve crop production and thus gain competitive edge over other companies.
Fruits and vegetables have been the world’s leading segment of the biobuilding industry and the estimated CAGR over the forecast years is expected to increase to over 12.0%. Increasing concerns about insects like citrus fruits, pome, and berry fruit, over the forecast period, are predicted to steer demand for insecticides and regulators.
What value propositions should businesses aim at while making new research and development funding in the Biorationals market?
High frequency of bug diseases and subsequent economic losses characterises the cereals and grain sectors. Cereal producers have been called upon to adopt agents such as pheromone traps and semi-chemicals for effective insect control to raise concerns about aphids. The endocrine system can be damaged by a high level of active ingredients and the metabolites degradation from the residues of cereals and vegetables. Ecolabel products are characterised by negligible MRL risks, providing enterprises with ample opportunities to boost their R&D investment and to develop effective products in the long term.
Biorationals Market – Our new market research study shows trends, developments, progress in R&D and forecast revenue till 2031.
What are the key factors to reshaping the growth of the Biorationals market? To find out, you must read this newly updated report if you are one of the stake holder of this market. This exclusive report by Visiongain shows you potential revenue opportunity pool until 2031 for the assessment of data, trends, opportunities and business outlooks.
Discover how to stay ahead
What are the most significant factors in the reshaping of business growth?
What patterns could lead to the expansion of the Biorationals market?
How do you tackle the negative effects of the pandemic of COVID 19?
What regions are champions of Biorationals market growth?
What will shift the industry in terms of its aspects?
What are the most recent developments on the Biorationals market?
214 tables and graphs are included in our 333 page report. Read about the most lucrative industries and the future prospects on the market. Our new study allows you to evaluate forecast sales worldwide and regional. See financial results, trends, opportunities and forecasts of revenue. In this growing Biorationals market a lot of opportunity remains. See how opportunities can be taken advantage of.
Forecasts to 2031 and other analyses reveal the commercial prospects of Biorationals Market
• In addition to revenue forecasting to 2031, our new study provides you with recent results, growth rates, and market shares.
• You find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), product profiles and commercial developments.
Discover sales predictions for the Biorationals market and submarkets
Global Biorationals Market by Type
Insecticides
Fungicides
Nematicides
Other Type
Global Biorationals Market by Source
Botanical
Microbial
Non-organic
Other Source
Global Biorationals Market by Application
Foliar spray
Soil treatment
Trunk injection
Other Application
Global Biorationals Market by Crop Type
Fruits & vegetables
Cereals & grains
Oilseeds & pulses
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 5 regional and 20 leading national markets:
• North America Biorationals Market Outlook
o U.S. Biorationals Market Forecast & COVID Impact Analysis
o Canada Biorationals Market Forecast & COVID Impact Analysis
• Europe Biorationals Market Outlook
o Germany Biorationals Market Forecast & COVID Impact Analysis
o France Biorationals Market Forecast & COVID Impact Analysis
o United Kingdom Biorationals Market Forecast & COVID Impact Analysis
o Italy Biorationals Market Forecast & COVID Impact Analysis
o Spain Biorationals Market Forecast & COVID Impact Analysis
o Rest of Europe Market Forecast & COVID Impact Analysis
• Asia Pacific Biorationals Market Outlook
o China Biorationals Market Forecast & COVID Impact Analysis
o Japan Biorationals Market Forecast & COVID Impact Analysis
o India Biorationals Market Forecast & COVID Impact Analysis
o Australia Biorationals Market Forecast & COVID Impact Analysis
o South Korea Biorationals Market Forecast & COVID Impact Analysis
o Rest of Asia Pacific Market Forecast & COVID Impact Analysis
• Latin America Biorationals Market Outlook Market Forecast & COVID Impact Analysis
o Brazil Biorationals Market Forecast & COVID Impact Analysis
o Mexico Biorationals Market Forecast & COVID Impact Analysis
o Argentina Biorationals Market Forecast & COVID Impact Analysis
o Rest of Latin America Market Forecast & COVID Impact Analysis
• Middle East and Africa Biorationals Market Outlook
o Turkey Biorationals Market Forecast & COVID Impact Analysis
o Saudi Arabia Biorationals Market Forecast & COVID Impact Analysis
o South Africa Biorationals Market Forecast & COVID Impact Analysis
o UAE Biorationals Market Forecast & COVID Impact Analysis
o Egypt Biorationals Market Forecast & COVID Impact Analysis
o Rest of Middle East and Africa
The report also includes profiles and for some of the leading companies in the Biorationals Market, with a focus on this segment of these companies’ operations.
Leading companies and the potential for market growth
Koppert B.V.
Bayer AG
Isagro SpA
Gowan Company LLC
Summit Chemical Company
Suterra LLC
Russell IPM
Agralan Ltd.
BASF SE
Rentokil Initial Plc
Overall world revenue for Biorationals Market will surpass $x million in 2020, our work calculates. We predict strong revenue growth through to 2031. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
How the Biorationals Market report helps you
In summary, our 320+ page report provides you with the following knowledge:
• Revenue forecasts to 2031 for Biorationals Market, with forecasts for Type, Source, Application, Crop Type each forecasted at a global and regional level– discover the industry’s prospects, finding the most lucrative places for investments and revenues
• Revenue forecasts to 2031 for 5 regional and 20 key national markets – See forecasts for the Biorationals market in North America, Europe, Asia-Pacific and LAMEA. Also forecasted is the market in the US, Canada, Argentina, Brazil, Germany, France, UK, Italy, Spain, China, India, Japan, and Australia among other prominent economies.
• Prospects for established firms and those seeking to enter the market– including company profiles for xx of the major companies involved in the Biorationals Market. Some of the company’s profiled in this report include xxx.
To access the data contained in this document please email contactus@visiongain.com
Buy our report today Biorationals Market Report to 2031: Forecasts by By Type (Insecticides, Fungicides, Nematicides) By Source (Botanical, Microbial, Non-organic) Application (Foliar spray, Soil treatment, Trunk injection) Crop Type (Fruits & vegetables, Cereals & grains, Oilseeds & pulses) PLUS COVID-19 Impact Analysis and Recovery Pattern Analysis (V-shaped, W-shaped, U-shaped, L-shaped) Profiles of Leading Companies, Region and Country. Avoid missing out by staying informed – order our report now.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com
1. Report Overview
1.1. Introduction
1.2. Why You Should Read This Report
1.3. Key Questions Answered by This Analytical Report
1.4. Who is This Report For?
1.5. Methodology
1.6. Frequently Asked Questions (FAQ)
1.7. Associated Visiongain Reports
1.8. About Visiongain
2. Introduction to the Biorationals Market
2.1. Biorationals Market Definition
2.2. Industry Terms Used in the Biorationals Market
2.3. Type Submarkets Definitions
2.4. Global Biorationals Market Characteristics
2.5. Global Biorationals Purchasers Analysis
2.6. Which are the Channels of distribution for Biorationals?
2.7. How Biorationals is Geographically distributed?
2.8. What are Supply and demand considerations for Biorationals?
2.9. What is the Status of Global Supply of Biorationals?
2.10. How much Demand for Biorationals in the Global Market?
2.11. Which are the Substitutability Issues for Biorationals?
2.12. What is the Lead times for Biorationals?
3. What are the key factors reshaping the growth of the Biorationals market?
3.1. Global Biorationals Market Size and Forecast by Region
3.2. Global Biorationals Market Share by Region
3.3. Market Dynamics
3.3.1. What are the Drivers Likely to Lead Market Growth?
3.3.1.1. Consumers today are more aware than ever of the quality of food they eat
3.3.1.2. Biorationals improve crop quality and are safe to humans and other non-target organisms
3.3.2. Which Factors Will Hinder Growth of Biorationals Market?
3.3.2.1. Low awareness about the Biorationals products
3.3.2.2. Low Efficiencies of few products
3.3.3. How Companies Can Encash Opportunities in the Biorationals Market?
3.3.3.1. Demand for this product segment is likely to be catered to by agriculture-driven countries
3.3.3.2. Natural plant products in this criterion have witnessed increasing demand for use as insecticides
3.3.4. Global Biorationals Market: Trends
3.3.4.1. Fruits and vegetables emerged as the leading segment in the global biorationals market
3.3.4.2. Stringent regulatory framework against synthetic pesticides has contributed tremendously toward product penetration in the global market
3.3.4.3. Increasing demand for low-priced and high-quality organic commodities
3.3.5. SWOT Analysis of Biorationals Market
3.3.5.1. What are the Strengths of the Biorationals Market?
3.3.5.1.1. High content of active ingredients and degradation of metabolites
3.3.5.1.2. Biorationals products figures prominently as sustainable solutions
3.3.5.2. What are the Weaknesses of the Biorationals Market?
3.3.5.2.1. Can’t Compete with Chemical Products
3.3.5.2.2. Low Marketing Promotions
3.3.5.3. Which Opportunities Does Biorationals Market Offers?
3.3.5.3.1. Increasing Trend of Organic Farming
3.3.5.3.2. Consumer Demand for Chemical Free Food
3.3.5.4. Which Threats to Watch in the Biorationals Market?
3.3.5.4.1. High Threat from substitutes
3.3.5.4.2. Stringent International Regulations
3.3.6. Porter’s Five Forces Analysis of Biorationals Market
3.3.6.1. How Intense is the Competition in the Global Biorationals Market?
3.3.6.2. Do Suppliers Have Power to Bargain?
3.3.6.3. How Buyer Can Play Power Game?
3.3.6.4. How to Tackle the Threat of Substitution in the Global Biorationals Market?
3.3.6.5. How Innovations from New Players Will Pose Threats to Market Leaders?
4. Global Biorationals Market Analysis and Forecast 2021-2031, by Type (Pre COVID and V, U, W and L COVID Recovery Scenarios)
4.1. Insecticides
4.1.1. Product Mapping and Analysis
4.1.2. Product Sales Trends
4.1.3. Advantages & Disadvantages of the Product
4.1.4. Market Size Estimation and Forecast, 2021-2031 (COVID Impact Analysis)
4.2. Fungicides
4.2.1. Product Mapping and Analysis
4.2.2. Product Sales Trends
4.2.3. Advantages & Disadvantages of the Product
4.2.4. Market Size Estimation and Forecast, 2021-2031 (COVID Impact Analysis)
4.3. Nematicides
4.3.1. Product Mapping and Analysis
4.3.2. Product Sales Trends
4.3.3. Advantages & Disadvantages of the Product
4.3.4. Market Size Estimation and Forecast, 2021-2031 (COVID Impact Analysis)
4.4. Other Type
4.4.1. Product Mapping and Analysis
4.4.2. Product Sales Trends
4.4.3. Advantages & Disadvantages of the Product
4.4.4. Market Size Estimation and Forecast, 2021-2031 (COVID Impact Analysis)
5. Global Biorationals Market Analysis and Forecast 2021-2031, by Source (Pre COVID and V, U, W and L COVID Recovery Scenarios)
5.1. Botanical
5.1.1. Global Biorationals Supply Elasticity
5.1.2. Global Biorationals Demand Elasticity
5.1.3. Biorationals Substitution Elasticity
5.1.4. Market Share Analysis
5.1.5. Market Estimation and Forecast, 2021-2031 (COVID Impact Analysis)
5.2. Microbial
5.2.1. Global Biorationals Supply Elasticity
5.2.2. Global Biorationals Demand Elasticity
5.2.3. Biorationals Substitution Elasticity
5.2.4. Market Share Analysis
5.2.5. Market Estimation and Forecast, 2021-2031 (COVID Impact Analysis)
5.3. Non-organic
5.3.1. Global Biorationals Supply Elasticity
5.3.2. Global Biorationals Demand Elasticity
5.3.3. Biorationals Substitution Elasticity
5.3.4. Market Share Analysis
5.3.5. Market Estimation and Forecast, 2021-2031 (COVID Impact Analysis)
5.4. Other Source
5.4.1. Global Biorationals Supply Elasticity
5.4.2. Global Biorationals Demand Elasticity
5.4.3. Biorationals Substitution Elasticity
5.4.4. Market Share Analysis
5.4.5. Market Estimation and Forecast, 2021-2031 (COVID Impact Analysis)
6. Global Biorationals Market Analysis and Forecast 2021-2031, by Application (Pre COVID and V, U, W and L COVID Recovery Scenarios)
6.1. Foliar spray
6.1.1. How much market share does this segment hold?
6.1.2. Which type of biorational are preferred by the purchaser?
6.1.3. What is the status of international trade of this product?
6.1.4. Market Estimation and Forecast, 2021-2031 (COVID Impact Analysis)
6.2. Soil treatment
6.2.1. How much market share does this segment hold?
6.2.2. Which type of biorational are preferred by the purchaser?
6.2.3. What is the status of international trade of this product?
6.2.4. Market Estimation and Forecast, 2021-2031 (COVID Impact Analysis)
6.3. Trunk injection
6.3.1. How much market share does this segment hold?
6.3.2. Which type of biorational are preferred by the purchaser?
6.3.3. What is the status of international trade of this product?
6.3.4. Market Estimation and Forecast, 2021-2031 (COVID Impact Analysis)
6.4. Other Application
6.4.1. How much market share does this segment hold?
6.4.2. Which type of biorational are preferred by the purchaser?
6.4.3. What is the status of international trade of this product?
6.4.4. Market Estimation and Forecast, 2021-2031 (COVID Impact Analysis)
7. Global Biorationals Market Analysis and Forecast 2021-2031, by Crop Type (Pre COVID and V, U, W and L COVID Recovery Scenarios)
7.1. Fruits & vegetables
7.1.1. Global Agriculture Land under Cultivation
7.1.2. Market Share of this Segment in the Global Market
7.1.3. Market Size Estimation and Forecast, 2021-2031 (COVID Impact Analysis)
7.2. Cereals & grains
7.2.1. Global Agriculture Land under Cultivation
7.2.2. Market Share of this Segment in the Global Market
7.2.3. Market Size Estimation and Forecast, 2021-2031 (COVID Impact Analysis)
7.3. Oilseeds & pulses
7.3.1. Global Agriculture Land under Cultivation
7.3.2. Market Share of this Segment in the Global Market
7.3.3. Market Size Estimation and Forecast, 2021-2031 (COVID Impact Analysis)
7.4. Other Crop Type
7.4.1. Global Agriculture Land under Cultivation
7.4.2. Market Share of this Segment in the Global Market
7.4.3. Market Size Estimation and Forecast, 2021-2031 (COVID Impact Analysis)
8. North America Biorationals Market Analysis and Forecast, 2021-2031 Pre COVID and V, U, W and L COVID Recovery Scenarios)
8.1. Market Overview
8.2. North America Biorationals Market Size and Forecast by Type
8.2.1. Insecticides Submarket Expected to Grow at Fastest Rate
8.3. North America Biorationals Market Size and Forecast by Source
8.3.1. Botanical Submarket to Grow at Fastest Rate
8.4. North America Biorationals Market Size and Forecast by Application
8.4.1. Fruits & Vegetables Submarket to Grow at Fastest Rate
8.5. U.S. Biorationals Market
8.5.1. What is the current status of Agriculture Industry in the country?
8.5.2. What is the GDP share of Agriculture in the Country?
8.5.3. Biorationals Production, Capacity, And Capacity Utilization
8.5.4. Biorationals Pricing Trend Analysis
8.5.5. Which factors will hinder the growth of the Biorationals market?
8.5.6. How COVID-19 Pandemic Lockdown has impacted the market?
8.5.7. Market Size Estimation and Forecast, 2021-2031
8.6. Canada Biorationals Market
8.6.1. What is the current status of Agriculture Industry in the country?
8.6.2. What is the GDP share of Agriculture in the Country?
8.6.3. Biorationals Production, Capacity, And Capacity Utilization
8.6.4. Biorationals Pricing Trend Analysis
8.6.5. Which factors will hinder the growth of the Biorationals market?
8.6.6. How COVID-19 Pandemic Lockdown has impacted the market?
8.6.7. Market Size Estimation and Forecast, 2021-2031
9. Europe Biorationals Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
9.1. Market Overview
9.2. Europe Biorationals Market Size and Forecast by Type
9.2.1. Insecticides Submarket Expected to Grow at Fastest Rate
9.3. Europe Biorationals Market Size and Forecast by Source
9.3.1. Botanical Submarket to Grow at Fastest Rate
9.4. Europe Biorationals Market Size and Forecast by Application
9.4.1. Fruits & Vegetables Submarket to Grow at Fastest Rate
9.5. UK Biorationals Market
9.5.1. What is the current status of Agriculture Industry in the country?
9.5.2. What is the GDP share of Agriculture in the Country?
9.5.3. Biorationals Production, Capacity, And Capacity Utilization
9.5.4. Biorationals Pricing Trend Analysis
9.5.5. Which factors will hinder the growth of the Biorationals market?
9.5.6. How COVID-19 Pandemic Lockdown has impacted the market?
9.5.7. Market Size Estimation and Forecast, 2021-2031
9.6. Germany Biorationals Market
9.6.1. What is the current status of Agriculture Industry in the country?
9.6.2. What is the GDP share of Agriculture in the Country?
9.6.3. Biorationals Production, Capacity, And Capacity Utilization
9.6.4. Biorationals Pricing Trend Analysis
9.6.5. Which factors will hinder the growth of the Biorationals market?
9.6.6. How COVID-19 Pandemic Lockdown has impacted the market?
9.6.7. Market Size Estimation and Forecast, 2021-2031
9.7. France Biorationals Market
9.7.1. What is the current status of Agriculture Industry in the country?
9.7.2. What is the GDP share of Agriculture in the Country?
9.7.3. Biorationals Production, Capacity, And Capacity Utilization
9.7.4. Biorationals Pricing Trend Analysis
9.7.5. Which factors will hinder the growth of the Biorationals market?
9.7.6. How COVID-19 Pandemic Lockdown has impacted the market?
9.7.7. Market Size Estimation and Forecast, 2021-2031
9.8. Italy Biorationals Market
9.8.1. What is the current status of Agriculture Industry in the country?
9.8.2. What is the GDP share of Agriculture in the Country?
9.8.3. Biorationals Production, Capacity, And Capacity Utilization
9.8.4. Biorationals Pricing Trend Analysis
9.8.5. Which factors will hinder the growth of the Biorationals market?
9.8.6. How COVID-19 Pandemic Lockdown has impacted the market?
9.8.7. Market Size Estimation and Forecast, 2021-2031
9.9. Spain Biorationals Market
9.9.1. What is the current status of Agriculture Industry in the country?
9.9.2. What is the GDP share of Agriculture in the Country?
9.9.3. Biorationals Production, Capacity, And Capacity Utilization
9.9.4. Biorationals Pricing Trend Analysis
9.9.5. Which factors will hinder the growth of the Biorationals market?
9.9.6. How COVID-19 Pandemic Lockdown has impacted the market?
9.9.7. Market Size Estimation and Forecast, 2021-2031
9.10. Rest of Europe Biorationals Market
9.10.1. What is the current status of Agriculture Industry in the country?
9.10.2. What is the GDP share of Agriculture in the Country?
9.10.3. Biorationals Production, Capacity, And Capacity Utilization
9.10.4. Biorationals Pricing Trend Analysis
9.10.5. Which factors will hinder the growth of the Biorationals market?
9.10.6. How COVID-19 Pandemic Lockdown has impacted the market?
9.10.7. Market Size Estimation and Forecast, 2021-2031
10. Asia Pacific Biorationals Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
10.1. Market Overview
10.2. Asia Pacific Biorationals Market Size and Forecast by Type
10.2.1. Insecticides Submarket Expected to Grow at Fastest Rate
10.3. Asia Pacific Biorationals Market Size and Forecast by Source
10.3.1. Botanical Submarket to Grow at Fastest Rate
10.4. Asia Pacific Biorationals Market Size and Forecast by Application
10.4.1. Fruits & Vegetables Submarket to Grow at Fastest Rate
10.5. China Biorationals Market
10.5.1. What is the current status of Agriculture Industry in the country?
10.5.2. What is the GDP share of Agriculture in the Country?
10.5.3. Biorationals Production, Capacity, And Capacity Utilization
10.5.4. Biorationals Pricing Trend Analysis
10.5.5. Which factors will hinder the growth of the Biorationals market?
10.5.6. How COVID-19 Pandemic Lockdown has impacted the market?
10.5.7. Market Size Estimation and Forecast, 2021-2031
10.6. India Biorationals Market
10.6.1. What is the current status of Agriculture Industry in the country?
10.6.2. What is the GDP share of Agriculture in the Country?
10.6.3. Biorationals Production, Capacity, And Capacity Utilization
10.6.4. Biorationals Pricing Trend Analysis
10.6.5. Which factors will hinder the growth of the Biorationals market?
10.6.6. How COVID-19 Pandemic Lockdown has impacted the market?
10.6.7. Market Size Estimation and Forecast, 2021-2031
10.7. Japan Biorationals Market
10.7.1. What is the current status of Agriculture Industry in the country?
10.7.2. What is the GDP share of Agriculture in the Country?
10.7.3. Biorationals Production, Capacity, And Capacity Utilization
10.7.4. Biorationals Pricing Trend Analysis
10.7.5. Which factors will hinder the growth of the Biorationals market?
10.7.6. How COVID-19 Pandemic Lockdown has impacted the market?
10.7.7. Market Size Estimation and Forecast, 2021-2031
10.8. Rest of Asia Pacific Biorationals Market
10.8.1. What is the current status of Agriculture Industry in the country?
10.8.2. What is the GDP share of Agriculture in the Country?
10.8.3. Biorationals Production, Capacity, And Capacity Utilization
10.8.4. Biorationals Pricing Trend Analysis
10.8.5. Which factors will hinder the growth of the Biorationals market?
10.8.6. How COVID-19 Pandemic Lockdown has impacted the market?
10.8.7. Market Size Estimation and Forecast, 2021-2031
11. Latin America Biorationals Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
11.1. Market Overview
11.2. Latin America Biorationals Market Size and Forecast by Type
11.2.1. Insecticides Submarket Expected to Grow at Fastest Rate
11.3. Latin America Biorationals Market Size and Forecast by Source
11.3.1. Botanical Submarket to Grow at Fastest Rate
11.4. Latin America Biorationals Market Size and Forecast by Application
11.4.1. Fruits & Vegetables Submarket to Grow at Fastest Rate
11.4.2. Brazil Biorationals Market
11.4.2.1. What is the current status of Agriculture Industry in the country?
11.4.2.2. What is the GDP share of Agriculture in the Country?
11.4.2.3. Biorationals Production, Capacity, And Capacity Utilization
11.4.2.4. Biorationals Pricing Trend Analysis
11.4.2.5. Which factors will hinder the growth of the Biorationals market?
11.4.2.6. How COVID-19 Pandemic Lockdown has impacted the market?
11.4.2.7. Market Size Estimation and Forecast, 2021-2031
11.4.3. Mexico Biorationals Market
11.4.3.1. What is the current status of Agriculture Industry in the country?
11.4.3.2. What is the GDP share of Agriculture in the Country?
11.4.3.3. Biorationals Production, Capacity, And Capacity Utilization
11.4.3.4. Biorationals Pricing Trend Analysis
11.4.3.5. Which factors will hinder the growth of the Biorationals market?
11.4.3.6. How COVID-19 Pandemic Lockdown has impacted the market?
11.4.3.7. Market Size Estimation and Forecast, 2021-2031
11.4.4. Rest of Latin America Biorationals Market
11.4.5. What is the current status of Agriculture Industry in the country?
11.4.6. What is the GDP share of Agriculture in the Country?
11.4.7. Biorationals Production, Capacity, And Capacity Utilization
11.4.8. Biorationals Pricing Trend Analysis
11.4.9. Which factors will hinder the growth of the Biorationals market?
11.4.10. How COVID-19 Pandemic Lockdown has impacted the market?
11.4.11. Market Size Estimation and Forecast, 2021-2031
12. MEA Biorationals Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
12.1. Market Overview
12.2. MEA Biorationals Market Size and Forecast by Type
12.2.1. Insecticides Submarket to Grow at Fastest Rate
12.3. MEA Biorationals Market Size and Forecast by Source
12.3.1. Microbial Submarket to Grow at Fastest Rate
12.4. MEA Biorationals Market Size and Forecast by Application
12.4.1. Fruits & Vegetables Submarket to Grow at Fastest Rate
12.5. GCC Biorationals Market
12.5.1. What is the current status of Agriculture Industry in the country?
12.5.2. What is the GDP share of Agriculture in the Country?
12.5.3. Biorationals Production, Capacity, And Capacity Utilization
12.5.4. Biorationals Pricing Trend Analysis
12.5.5. Which factors will hinder the growth of the Biorationals market?
12.5.6. How COVID-19 Pandemic Lockdown has impacted the market?
12.5.7. Market Size Estimation and Forecast, 2021-2031
12.6. South Africa Biorationals Market
12.6.1. What is the current status of Agriculture Industry in the country?
12.6.2. What is the GDP share of Agriculture in the Country?
12.6.3. Biorationals Production, Capacity, And Capacity Utilization
12.6.4. Biorationals Pricing Trend Analysis
12.6.5. Which factors will hinder the growth of the Biorationals market?
12.6.6. How COVID-19 Pandemic Lockdown has impacted the market?
12.6.7. Market Size Estimation and Forecast, 2021-2031
12.7. Rest of MEA Biorationals Market
12.7.1. What is the current status of Agriculture Industry in the country?
12.7.2. What is the GDP share of Agriculture in the Country?
12.7.3. Biorationals Production, Capacity, And Capacity Utilization
12.7.4. Biorationals Pricing Trend Analysis
12.7.5. Which factors will hinder the growth of the Biorationals market?
12.7.6. How COVID-19 Pandemic Lockdown has impacted the market?
12.7.7. Market Size Estimation and Forecast, 2021-2031
13. Companies in the Biorationals Market
13.1. Koppert B.V.
13.1.1. Company Snapshot
13.1.2. Company Overview
13.1.3. Financial Performance (2015-2019)
13.1.3.1. Net Revenue
13.1.3.2. Gross Profit
13.1.3.3. Geographical Revenue, 2019
13.1.4. Product Offerings
13.1.5. Recent Developments (2017-2020)
13.2. Bayer AG
13.2.1. Company Snapshot
13.2.2. Company Overview
13.2.3. Financial Performance (2015-2019)
13.2.3.1. Net Revenue
13.2.3.2. Gross Profit
13.2.3.3. Geographical Revenue, 2019
13.2.4. Product Offerings
13.2.5. Recent Developments (2017-2020)
13.3. Isagro SpA
13.3.1. Company Snapshot
13.3.2. Company Overview
13.3.3. Financial Performance (2015-2019)
13.3.3.1. Net Revenue
13.3.3.2. Gross Profit
13.3.3.3. Geographical Revenue, 2019
13.3.4. Product Offerings
13.3.5. Recent Developments (2017-2020)
13.4. Gowan Company LLC
13.4.1. Company Snapshot
13.4.2. Company Overview
13.4.3. Financial Performance (2015-2019)
13.4.3.1. Net Revenue
13.4.3.2. Gross Profit
13.4.3.3. Geographical Revenue, 2019
13.4.4. Product Offerings
13.4.5. Recent Developments (2017-2020)
13.5. Summit Chemical Company
13.5.1. Company Snapshot
13.5.2. Company Overview
13.5.3. Financial Performance (2015-2019)
13.5.3.1. Net Revenue
13.5.3.2. Gross Profit
13.5.3.3. Geographical Revenue, 2019
13.5.4. Product Offerings
13.5.5. Recent Developments (2017-2020)
13.6. Suterra LLC
13.6.1. Company Snapshot
13.6.2. Company Overview
13.6.3. Financial Performance (2015-2019)
13.6.3.1. Net Revenue
13.6.3.2. Gross Profit
13.6.3.3. Geographical Revenue, 2019
13.6.4. Product Offerings
13.6.5. Recent Developments (2017-2020)
13.7. Russell IPM
13.7.1. Company Snapshot
13.7.2. Company Overview
13.7.3. Financial Performance (2015-2019)
13.7.3.1. Net Revenue
13.7.3.2. Gross Profit
13.7.3.3. Geographical Revenue, 2019
13.7.4. Product Offerings
13.7.5. Recent Developments (2017-2020)
13.8. Agralan Ltd.
13.8.1. Company Snapshot
13.8.2. Company Overview
13.8.3. Financial Performance (2015-2019)
13.8.3.1. Net Revenue
13.8.3.2. Gross Profit
13.8.3.3. Geographical Revenue, 2019
13.8.4. Product Offerings
13.8.5. Recent Developments (2017-2020)
13.9. BASF SE
13.9.1. Company Snapshot
13.9.2. Company Overview
13.9.3. Financial Performance (2015-2019)
13.9.3.1. Net Revenue
13.9.3.2. Gross Profit
13.9.3.3. Geographical Revenue, 2019
13.9.4. Product Offerings
13.9.5. Recent Developments (2017-2020)
13.10. Rentokil Initial Plc
13.10.1. Company Snapshot
13.10.2. Company Overview
13.10.3. Financial Performance (2015-2019)
13.10.3.1. Net Revenue
13.10.3.2. Gross Profit
13.10.3.3. Geographical Revenue, 2019
13.10.4. Product Offerings
13.10.5. Recent Developments (2017-2020)
13.11. Other Notable Players
14. Conclusion
15. Glossary
Associated Visiongain Reports
Visiongain Report Sales Order Form
Appendix A
About Visiongain
Appendix B
Visiongain report evaluation form
LIST OF TABLES
Table 1. Biorationals Market Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (Before COVID)
Table 2. Biorationals Market Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 3. Biorationals Market Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 4. Biorationals Market Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 5. Biorationals Market Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 6. Biorationals Market Drivers & Restraints 2020
Table 7. Biorationals Submarket Forecast by Nematicides 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 8. Biorationals Submarket Forecast by Nematicides 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 9. Biorationals Submarket Forecast by Nematicides 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 10. Biorationals Submarket Forecast by Nematicides 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 11. Biorationals Submarket Forecast by Nematicides 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 12. Non-organic Submarket Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (Before COVID)
Table 13. Non-organic Submarket Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 14. Non-organic Submarket Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 15. Non-organic Submarket Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 16. Non-organic Submarket Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 17. Foliar spray Submarket Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (Before COVID)
Table 18. Foliar spray Submarket Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 19. Foliar spray Submarket Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 20. Foliar spray Submarket Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 21. Foliar spray Submarket Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 22. Fruits & vegetables Submarket Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (Before COVID)
Table 23. Fruits & vegetables Submarket Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 24. Fruits & vegetables Submarket Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 25. Fruits & vegetables Submarket Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 26. Fruits & vegetables Submarket Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 27. Cereals & grains Submarket Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (Before COVID)
Table 28. Cereals & grains Submarket Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 29. Cereals & grains Submarket Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 30. Cereals & grains Submarket Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 31. Cereals & grains Submarket Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 32. Biorationals Submarket Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 33. Biorationals Submarket Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 34. Biorationals Submarket Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 35. Biorationals Submarket Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 36. Biorationals Submarket Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 37. Others Submarket Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (Before COVID)
Table 38. Others Submarket Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 39. Others Submarket Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 40. Others Submarket Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 41. Others Submarket Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 42. Insecticides Submarket Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (Before COVID)
Table 43. Insecticides Submarket Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 44. Insecticides Submarket Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 45. Insecticides Submarket Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 46. Insecticides Submarket Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 47. Fungicides Submarket Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (Before COVID)
Table 48. Fungicides Submarket Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 49. Fungicides Submarket Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 50. Fungicides Submarket Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 51. Fungicides Submarket Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 52. Nematicides Submarket Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (Before COVID)
Table 53. Nematicides Submarket Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 54. Nematicides Submarket Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 55. Nematicides Submarket Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 56. Nematicides Submarket Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 57. Botanical Submarket Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (Before COVID)
Table 58. Botanical Submarket Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 59. Botanical Submarket Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 60. Botanical Submarket Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 61. Botanical Submarket Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 62. Microbial Submarket Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (Before COVID)
Table 63. Microbial Submarket Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 64. Microbial Submarket Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 65. Microbial Submarket Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 66. Microbial Submarket Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 67. Others Submarket Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (Before COVID)
Table 68. Others Submarket Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 69. Others Submarket Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 70. Others Submarket Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 71. Others Submarket Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 72. Biorationals Market Forecast by Application 2021-2031 (US$ Mn, AGR %, CAGR %) (Before COVID)
Table 73. Biorationals Market Forecast by Application 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 74. Biorationals Market Forecast by Application 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 75. Biorationals Market Forecast by Application 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 76. Biorationals Market Forecast by Application 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 77. Regional Biorationals Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 78. Regional Biorationals Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 79. Regional Biorationals Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 80. Regional Biorationals Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 81. Regional Biorationals Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 82. North America Biorationals Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 83. North America Biorationals Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 84. North America Biorationals Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 85. North America Biorationals Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 86. North America Biorationals Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 87. North America Biorationals Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 88. North America Biorationals Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 89. North America Biorationals Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 90. North America Biorationals Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 91. North America Biorationals Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 92. North America Biorationals Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 93. North America Biorationals Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 94. North America Biorationals Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 95. North America Biorationals Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 96. North America Biorationals Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 97. US Biorationals Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 98. US Biorationals Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 99. US Biorationals Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 100. US Biorationals Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 101. US Biorationals Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 102. US Biorationals Market Dynamics
Table 103. Canada Biorationals Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 104. Canada Biorationals Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 105. Canada Biorationals Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 106. Canada Biorationals Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 107. Canada Biorationals Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 108. Canada Biorationals Market Dynamics
Table 109. Europe Biorationals Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 110. Europe Biorationals Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table Insecticides. Europe Biorationals Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 112. Europe Biorationals Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 113. Europe Biorationals Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 114. Europe Biorationals Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 115. Europe Biorationals Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 116. Europe Biorationals Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 117. Europe Biorationals Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 118. Europe Biorationals Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 119. Europe Biorationals Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 120. Europe Biorationals Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 121. Europe Biorationals Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 122. Europe Biorationals Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 123. Europe Biorationals Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 124. UK Biorationals Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 125. UK Biorationals Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 126. UK Biorationals Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 127. UK Biorationals Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 128. UK Biorationals Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 129. UK Biorationals Market Dynamics
Table 130. Germany Biorationals Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 131. Germany Biorationals Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 132. Germany Biorationals Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 133. Germany Biorationals Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 134. Germany Biorationals Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 135. Germany Biorationals Market Dynamics
Table 136. France Biorationals Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 137. France Biorationals Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 138. France Biorationals Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 139. France Biorationals Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 140. France Biorationals Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 141. France Biorationals Market Dynamics
Table 142. Rest of Europe Biorationals Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 143. Rest of Europe Biorationals Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 144. Rest of Europe Biorationals Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 145. Rest of Europe Biorationals Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 146. Rest of Europe Biorationals Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 147. Asia Pacific Biorationals Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 148. Asia Pacific Biorationals Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 149. Asia Pacific Biorationals Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 150. Asia Pacific Biorationals Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 151. Asia Pacific Biorationals Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 152. Asia Pacific Biorationals Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 153. Asia Pacific Biorationals Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 154. Asia Pacific Biorationals Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 155. Asia Pacific Biorationals Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 156. Asia Pacific Biorationals Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 157. Asia Pacific Biorationals Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 158. Asia Pacific Biorationals Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 159. Asia Pacific Biorationals Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 160. Asia Pacific Biorationals Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 161. Asia Pacific Biorationals Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 162. China Biorationals Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 163. China Biorationals Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 164. China Biorationals Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 165. China Biorationals Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 166. China Biorationals Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 167. China Biorationals Market Dynamics
Table 168. India Biorationals Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 169. India Biorationals Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 170. India Biorationals Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 171. India Biorationals Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 172. India Biorationals Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 173. India Biorationals Market Dynamics
Table 174. Japan Biorationals Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 175. Japan Biorationals Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 176. Japan Biorationals Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 177. Japan Biorationals Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 178. Japan Biorationals Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 179. Japan Biorationals Market Dynamics
Table 180. RoAPAC Biorationals Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 181. RoAPAC Biorationals Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 182. RoAPAC Biorationals Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 183. RoAPAC Biorationals Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 184. RoAPAC Biorationals Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 185. Middle East Biorationals Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 186. Middle East Biorationals Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 187. Middle East Biorationals Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 188. Middle East Biorationals Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 189. Middle East Biorationals Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 190. Middle East Biorationals Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 191. Middle East Biorationals Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 192. Middle East Biorationals Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 193. Middle East Biorationals Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 194. Middle East Biorationals Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 195. Latin America Biorationals Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 196. Latin America Biorationals Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 197. Latin America Biorationals Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 198. Latin America Biorationals Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 199. Latin America Biorationals Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 200. Latin America Biorationals Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 201. Latin America Biorationals Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 202. Latin America Biorationals Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 203. Latin America Biorationals Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 204. Latin America Biorationals Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 205. Africa Biorationals Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 206. Africa Biorationals Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 207. Africa Biorationals Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 208. Africa Biorationals Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 209. Africa Biorationals Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 210. Africa Biorationals Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 211. Africa Biorationals Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 212. Africa Biorationals Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 213. Africa Biorationals Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 214. Africa Biorationals Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 215. Leading 10 Biorationals Companies (Ranking, Company, Latest Total Company Sales US$M*, HQ)
Table 216. Koppert B.V. Profile 2020 (CEO, HQ, Founded, Website)
Table 217. Koppert B.V. Biorationals Selected Recent Developments 2019 (Date, Development Type, Details)
Table 218. Koppert B.V. Product Offering (Segment, Product Offerings)
Table 219. Bayer AG Profile 2020 (CEO, HQ, Founded, Website)
Table 220. Bayer AG Product Offering (Segment, Product Offerings)
Table 221. Isagro SpA Profile 2020 (CEO, HQ, Founded, Website)
Table Fungicides. Isagro SpA Biorationals Selected Recent Developments 2017-2019 (Date, Development Type, Details)
Table 223. Isagro SpA Product Offering (Segment, Product Offerings)
Table 224. Gowan Company LLC Profile 2020 (CEO, HQ, Founded, Website)
Table 225. Gowan Company LLC Selected Recent Developments 2015-2019 (Date, Development Type, Details)
Table 226. Gowan Company LLC Product Offering (Segment, Product Offerings)
Table 227. Summit Chemical Company Profile 2020 (CEO, HQ, Founded, Website)
Table 228. Summit Chemical Company Product Offering (Segment, Product Offerings)
Table 229. Suterra LLC Profile 2020 (CEO, HQ, Founded, Website)
Table 230. Suterra LLC Selected Recent Developments 2015-2019 (Date, Development Type, Details)
Table 231. Suterra LLC Product Offering (Segment, Product Offerings)
Table 232. Russell IPM Profile 2020 (CEO, HQ, Founded, Website)
Table 233. Russell IPM Product Offering (Segment, Product Offerings)
Table 234. Agralan Ltd. Profile 2020 (CEO, HQ, Founded, Website)
Table 235. Agralan Ltd. Product Offering (Segment, Product Offerings)
Table 236. BASF SE, Inc Profile 2020 (CEO, HQ, Founded, Website)
Table 237. BASF SE Product Offering (Segment, Product Offerings)
Table 238. Rentokil Initial Plc Profile 2020 (CEO, Total Company Sales US$m, HQ, Founded, No. of Employees, Ticker, Website)
Table 239. Rentokil Initial Plc, Total Company Sales 2015-2019 (US$m, AGR %)
Table 240. Rentokil Initial Plc Sales by Segment of Business 2019 (US$m)
Table 241. Rentokil Initial Plc Sales by Regional Segment of Business 2019 (US$m)
Table 242. Rentokil Initial Plc Product Offering (Segment, Product Offerings)
Table 243. Other Companies Involved in the Biorationals Market 2020 (Company, Location)
LIST OF FIGURES
Figure 1. Biorationals Market Type Overview
Figure 2. Biorationals Market Source Overview
Figure 3. Biorationals Market Application Overview
Figure 4. Biorationals Market Forecast 2021-2031 (US$M, AGR %) (Before COVID)
Figure 5. Biorationals Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 6. Biorationals Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 7. Biorationals Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 8. Biorationals Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 9. Biorationals Submarket Forecast by Type 2021-2031 (US$M, Global AGR %) (Before COVID)
Figure 10. Biorationals Submarket Forecast by Type 2021-2031 (US$M, Global AGR %) (COVID - Scenario V)
Figure 11. Biorationals Submarket Forecast by Type 2021-2031 (US$M, Global AGR %) (COVID - Scenario U)
Figure 12. Biorationals Submarket Forecast by Type 2021-2031 (US$M, Global AGR %) (COVID - Scenario W)
Figure 13. Biorationals Submarket Forecast by Type 2021-2031 (US$M, Global AGR %) (COVID - Scenario L)
Figure 14. Non-organic Submarket Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (Before COVID)
Figure 15. Non-organic Submarket Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID – Scenario V)
Figure 16. Non-organic Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario U)
Figure 17. Non-organic Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario W)
Figure 18. Non-organic Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario L)
Figure 19. Foliar spray Submarket Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (Before COVID)
Figure 20. Foliar spray Submarket Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID – Scenario V)
Figure 21. Foliar spray Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario U)
Figure 22. Foliar spray Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario W)
Figure 23. Foliar spray Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario L)
Figure 24. Fruits & vegetables Submarket Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (Before COVID)
Figure 25. Fruits & vegetables Submarket Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID – Scenario V)
Figure 26. Fruits & vegetables Submarket Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID – Scenario U)
Figure 27. Fruits & vegetables Submarket Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID – Scenario W)
Figure 28. Fruits & vegetables Submarket Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID – Scenario L)
Figure 29. Cereals & grains Submarket Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (Before COVID)
Figure 30. Cereals & grains Submarket Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID – Scenario V)
Figure 31. Cereals & grains Submarket Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID – Scenario U)
Figure 32. Cereals & grains Submarket Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID – Scenario W)
Figure 33. Cereals & grains Submarket Forecast 2021-2031 (US$ Mn, AGR %, CAGR %) (COVID – Scenario L)
Figure 34. Biorationals Submarket Forecast by Source 2021-2031 (US$M, Global AGR %) (Before COVID)
Figure 35. Biorationals Submarket Forecast by Source 2021-2031 (US$M, Global AGR %) (COVID - Scenario V)
Figure 36. Biorationals Submarket Forecast by Source 2021-2031 (US$M, Global AGR %) (COVID - Scenario U)
Figure 37. Biorationals Submarket Forecast by Source 2021-2031 (US$M, Global AGR %) (COVID - Scenario W)
Figure 38. Biorationals Submarket Forecast by Source 2021-2031 (US$M, Global AGR %) (COVID - Scenario L)
Figure 39. Others Submarket Forecast 2021-2031 (US$M, Global AGR %) (Before COVID)
Figure 40. Others Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario V)
Figure 41. Others Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario U)
Figure 42. Others Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario W)
Figure 43. Others Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario L)
Figure 44. Insecticides Submarket Forecast 2021-2031 (US$M, Global AGR %) (Before COVID)
Figure 45. Insecticides Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario V)
Figure 46. Insecticides Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario U)
Figure 47. Insecticides Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario W)
Figure 48. Insecticides Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario L)
Figure 49. Fungicides Submarket Forecast 2021-2031 (US$M, Global AGR %) (Before COVID)
Figure 50. Fungicides Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario V)
Figure 51. Fungicides Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario U)
Figure 52. Fungicides Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario W)
Figure 53. Fungicides Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario W)
Figure 54. Nematicides Submarket Forecast 2021-2031 (US$M, Global AGR %) (Before COVID)
Figure 55. Nematicides Submarket Forecast 2021-2031 (US$M, Global AGR %) (Before COVID)
Figure 56. Nematicides Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario U)
Figure 57. Nematicides Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario W)
Figure 58. Nematicides Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario W)
Figure 59. Botanical Submarket Forecast 2021-2031 (US$M, Global AGR %) (Before COVID)
Figure 60. Botanical Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario V)
Figure 61. Botanical Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario U)
Figure 62. Botanical Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario W)
Figure 63. Botanical Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario L)
Figure 64. Microbial Submarket Forecast 2021-2031 (US$M, Global AGR %) (Before COVID)
Figure 65. Microbial Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario V)
Figure 66. Microbial Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario U)
Figure 67. Microbial Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario W)
Figure 68. Microbial Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario L)
Figure 69. Others Submarket Forecast 2021-2031 (US$M, Global AGR %) (Before COVID)
Figure 70. Others Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario V)
Figure 71. Others Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario U)
Figure 72. Others Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario W)
Figure 73. Others Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario L)
Figure 74. Biorationals Submarket Forecast by Application 2021-2031 (US$M, Global AGR %) (Before COVID)
Figure 75. Biorationals Submarket Forecast by Application 2021-2031 (US$M, Global AGR %) (COVID - Scenario V)
Figure 76. Biorationals Submarket Forecast by Application 2021-2031 (US$M, Global AGR %) (COVID - Scenario U)
Figure 77. Biorationals Submarket Forecast by Application 2021-2031 (US$M, Global AGR %) (COVID - Scenario W)
Figure 78. Biorationals Submarket Forecast by Application 2021-2031 (US$M, Global AGR %) (COVID - Scenario L)
Figure 79. Regional Biorationals Market Forecast 2021-2031 (Sales US$M, Global AGR %)
Figure 80. Regional Biorationals Market Forecast 2021-2031 (Sales US$M, Global AGR %) (COVID - Scenario V)
Figure 81. Regional Biorationals Market Forecast 2021-2031 (Sales US$M, Global AGR %) (COVID - Scenario U)
Figure 82. Regional Biorationals Market Forecast 2021-2031 (Sales US$M, Global AGR %) (COVID - Scenario W)
Figure 83. Regional Biorationals Market Forecast 2021-2031 (Sales US$M, Global AGR %) (COVID - Scenario L)
Figure 84. North America Biorationals Market Forecast by Type 2021-2031 (US$M, AGR %) (Before COVID)
Figure 85. North America Biorationals Market Forecast by Type 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 86. North America Biorationals Market Forecast by Type 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 87. North America Biorationals Market Forecast by Type 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 88. North America Biorationals Market Forecast by Type 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 89. North America Biorationals Market Forecast by Source 2021-2031 (US$M, AGR %)
Figure 90. North America Biorationals Market Forecast by Source 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 91. North America Biorationals Market Forecast by Source 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 92. North America Biorationals Market Forecast by Source 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 93. North America Biorationals Market Forecast by Source 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 94. North America Biorationals Market Forecast by Country 2021-2031 (US$M, AGR %) (Before COVID)
Figure 95. North America Biorationals Market Forecast by Country 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 96. North America Biorationals Market Forecast by Country 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 97. North America Biorationals Market Forecast by Country 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 98. North America Biorationals Market Forecast by Country 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 99. US Biorationals Market Forecast 2021-2031 (US$M, AGR %) (Before COVID)
Figure 100. US Biorationals Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 101. US Biorationals Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 102. US Biorationals Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 103. US Biorationals Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 104. Canada Biorationals Market Forecast 2021-2031 (US$M, AGR %)
Figure 105. Canada Biorationals Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 106. Canada Biorationals Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 107. Canada Biorationals Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 108. Canada Biorationals Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 109. Europe Biorationals Market Forecast by Type 2021-2031 (US$M)
Figure 110. Europe Biorationals Market Forecast by Type 2021-2031 (US$M) (COVID - Scenario V)
Figure Insecticides. Europe Biorationals Market Forecast by Type 2021-2031 (US$M) (COVID - Scenario U)
Figure 112. Europe Biorationals Market Forecast by Type 2021-2031 (US$M) (COVID - Scenario W)
Figure 113. Europe Biorationals Market Forecast by Type 2021-2031 (US$M) (COVID - Scenario L)
Figure 114. Europe Biorationals Market Forecast by Source 2021-2031 (US$M) (Before COVID)
Figure 115. Europe Biorationals Market Forecast by Source 2021-2031 (US$M) (COVID - Scenario V)
Figure 116. Europe Biorationals Market Forecast by Source 2021-2031 (US$M) (COVID - Scenario U)
Figure 117. Europe Biorationals Market Forecast by Source 2021-2031 (US$M) (COVID - Scenario W)
Figure 118. Europe Biorationals Market Forecast by Source 2021-2031 (US$M) (COVID - Scenario L)
Figure 119. Europe Biorationals Market Forecast by Country 2021-2031 (US$M, Global AGR %) (Before COVID)
Figure 120. Europe Biorationals Market Forecast by Country 2021-2031 (US$M, Global AGR %) (COVID - Scenario V)
Figure 121. Europe Biorationals Market Forecast by Country 2021-2031 (US$M, Global AGR %) (COVID - Scenario U)
Figure 122. Europe Biorationals Market Forecast by Country 2021-2031 (US$M, Global AGR %) (COVID - Scenario W)
Figure 123. Europe Biorationals Market Forecast by Country 2021-2031 (US$M, Global AGR %) (COVID - Scenario L)
Figure 124. UK Biorationals Market Forecast 2021-2031 (US$M, AGR %) (Before COVID)
Figure 125. UK Biorationals Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 126. UK Biorationals Market Forecast 2021-2031 (US$M, AGR %) (COVID – Scenario U)
Figure 127. UK Biorationals Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 128. UK Biorationals Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 129. Germany Biorationals Market Forecast 2021-2031 (US$M, AGR %)
Figure 130. Germany Biorationals Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 131. Germany Biorationals Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 132. Germany Biorationals Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 133. Germany Biorationals Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 134. France Biorationals Market Forecast 2021-2031 (US$M, AGR %)
Figure 135. France Biorationals Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 136. France Biorationals Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 137. France Biorationals Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 138. France Biorationals Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 139. Rest of Europe Biorationals Market Forecast 2021-2031 (US$M, AGR %) (Before COVID)
Figure 140. Rest of Europe Biorationals Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 141. Rest of Europe Biorationals Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 142. Rest of Europe Biorationals Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 143. Rest of Europe Biorationals Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 144. Asia-Pacific Biorationals Market Forecast by Type 2021-2031 (US$M) (Before COVID)
Figure 145. Asia-Pacific Biorationals Market Forecast by Type 2021-2031 (US$M) (COVID - Scenario V)
Figure 146. Asia-Pacific Biorationals Market Forecast by Type 2021-2031 (US$M) (COVID - Scenario U)
Figure 147. Asia-Pacific Biorationals Market Forecast by Type 2021-2031 (US$M) (COVID - Scenario W)
Figure 148. Asia-Pacific Biorationals Market Forecast by Type 2021-2031 (US$M) (COVID - Scenario L)
Figure 149. Asia-Pacific Biorationals Market Forecast by Source 2021-2031 (US$M)
Figure 150. Asia-Pacific Biorationals Market Forecast by Source 2021-2031 (US$M) (COVID - Scenario V)
Figure 151. Asia-Pacific Biorationals Market Forecast by Source 2021-2031 (US$M) (COVID - Scenario U)
Figure 152. Asia-Pacific Biorationals Market Forecast by Source 2021-2031 (US$M) (COVID - Scenario W)
Figure 153. Asia-Pacific Biorationals Market Forecast by Source 2021-2031 (US$M) (COVID - Scenario L)
Figure 154. Asia-Pacific Biorationals Market Forecast by Country 2021-2031 (US$M, AGR %) (Before COVID)
Figure 155. Asia-Pacific Biorationals Market Forecast by Country 2021-2031 (US$M, Global AGR %) (COVID - Scenario V)
Figure 156. Asia-Pacific Biorationals Market Forecast by Country 2021-2031 (US$M, Global AGR %) (COVID - Scenario U)
Figure 157. Asia-Pacific Biorationals Market Forecast by Country 2021-2031 (US$M, Global AGR %) (COVID - Scenario W)
Figure 158. Asia-Pacific Biorationals Market Forecast by Country 2021-2031 (US$M, Global AGR %) (COVID - Scenario L)
Figure 159. China Biorationals Market Forecast 2021-2031 (US$M, AGR %)
Figure 160. China Biorationals Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 161. China Biorationals Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 162. China Biorationals Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 163. China Biorationals Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 164. India Biorationals Market Forecast 2021-2031 (US$M, AGR %)
Figure 165. India Biorationals Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 166. India Biorationals Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 167. India Biorationals Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 168. India Biorationals Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 169. Japan Biorationals Market Forecast 2021-2031 (US$M, AGR %) (Before COVID)
Figure 170. Japan Biorationals Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 171. Japan Biorationals Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 172. Japan Biorationals Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 173. Japan Biorationals Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 174. Rest of APAC Biorationals Market Forecast 2021-2031 (US$M, AGR %) (Before COVID)
Figure 175. Rest of APAC Biorationals Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 176. Rest of APAC Biorationals Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 177. Rest of APAC Biorationals Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 178. Rest of APAC Biorationals Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 179. Middle East Biorationals Market Forecast by Type 2021-2031 (US$M)
Figure 180. Middle East Biorationals Market Forecast by Type 2021-2031 (US$M) (COVID - Scenario V)
Figure 181. Middle East Biorationals Market Forecast by Type 2021-2031 (US$M) (COVID - Scenario U)
Figure 182. Middle East Biorationals Market Forecast by Type 2021-2031 (US$M) (COVID - Scenario W)
Figure 183. Middle East Biorationals Market Forecast by Type 2021-2031 (US$M) (COVID - Scenario L)
Figure 184. Middle East Biorationals Market Forecast by Source 2021-2031 (US$M)
Figure 185. Middle East Biorationals Market Forecast by Source 2021-2031 (US$M) (COVID - Scenario V)
Figure 186. Middle East Biorationals Market Forecast by Source 2021-2031 (US$M) (COVID - Scenario U)
Figure 187. Middle East Biorationals Market Forecast by Source 2021-2031 (US$M) (COVID - Scenario W)
Figure 188. Middle East Biorationals Market Forecast by Source 2021-2031 (US$M) (COVID - Scenario L)
Figure 189. Latin America Biorationals Market Forecast by Type 2021-2031 (US$M)
Figure 190. Latin America Biorationals Market Forecast by Type 2021-2031 (US$M) (COVID - Scenario V)
Figure 191. Latin America Biorationals Market Forecast by Type 2021-2031 (US$M) (COVID - Scenario U)
Figure 192. Latin America Biorationals Market Forecast by Type 2021-2031 (US$M) (COVID - Scenario W)
Figure 193. Latin America Biorationals Market Forecast by Type 2021-2031 (US$M) (COVID - Scenario L)
Figure 194. Latin America Biorationals Market Forecast by Source 2021-2031 (US$M)
Figure 195. Latin America Biorationals Market Forecast by Source 2021-2031 (US$M) (COVID - Scenario V)
Figure 196. Latin America Biorationals Market Forecast by Source 2021-2031 (US$M) (COVID - Scenario U)
Figure 197. Latin America Biorationals Market Forecast by Source 2021-2031 (US$M) (COVID - Scenario W)
Figure 198. Latin America Biorationals Market Forecast by Source 2021-2031 (US$M) (COVID - Scenario L)
Figure 199. Africa Biorationals Market Forecast by Type 2021-2031 (US$M)
Figure 200. Africa Biorationals Market Forecast by Type 2021-2031 (US$M) (COVID - Scenario V)
Figure 201. Africa Biorationals Market Forecast by Type 2021-2031 (US$M) (COVID - Scenario U)
Figure 202. Africa Biorationals Market Forecast by Type 2021-2031 (US$M) (COVID - Scenario W)
Figure 203. Africa Biorationals Market Forecast by Type 2021-2031 (US$M) (COVID - Scenario L)
Figure 204. Africa Biorationals Market Forecast by Source 2021-2031 (US$M) (Before COVID)
Figure 205. Africa Biorationals Market Forecast by Source 2021-2031 (US$M) (COVID - Scenario V)
Figure 206. Africa Biorationals Market Forecast by Source 2021-2031 (US$M) (COVID - Scenario U)
Figure 207. Africa Biorationals Market Forecast by Source 2021-2031 (US$M) (COVID - Scenario W)
Figure 208. Africa Biorationals Market Forecast by Source 2021-2031 (US$M) (COVID - Scenario L)
Figure 209. Porter’s Five Force Analysis
Figure 210. Rentokil Initial Plc Total Company Sales 2015-2019 (US$m, AGR %)
Figure 211. Rentokil Initial Plc Sales by Segment of Business 2019 (US$m)
Figure 212. Rentokil Initial Plc Sales by Regional Segment of Business 2019 (US$m)
Profiles of Key Players in Biorationals market
Koppert B.V.
Bayer AG
Isagro SpA
Gowan Company LLC
Summit Chemical Company
Suterra LLC
Russell IPM
Agralan Ltd.
BASF SE
Rentokil Initial Plc
Other Companies Mentioned in the Report
McLaughin Gormley King
Inora
Syngenta
Monsanto Bioag
Dowdupont
Valent Biosciences
Marrone Bio Innovations
Prisms India Private Limited
Godrej Agrovet Limited
Navagro
Safsorganic
BioAg Syngenta Isagro SPA inc
Bio Innovations
Bioworks, Inc.
E. I. Du Pont Nemours & Company
Nufarm Limited
Sipcam Agro USA, Inc.
LLC
Agbitech Pvt.Ltd.
Agrauxine SA
List of Organizations relate to Biorationals market
Puerto Rico Pest Control Association
The International HCH & Pesticides Association
Australian Pest Controllers Association
Global Crop Protection Federation
Chinese Pest Control Association
Pesticide Action Network (PAN)
Pest Control Association of The Philippines
The Organization for Economic Cooperation and Development (OECD) (OECD Working Group)
International Professional Women in Pest Management
Indonesian Pest Control Association
Pesticide Action Network North America (PANNA)
The National Association of Pest Control Companies
Global Recognition Campaign for Multiple Chemical Sensitivity
Global Pest Management Coalition
Argentine Association of Pest Control Businesses
Pest Management Association of Kenya
South African Pest Control Association
CropLife International
global pest management associations
Association of American Pesticide Control Officials (AAPCO)
Termite & Pest Control Associations
Taiwan Environmental Pest Management Association
European Pest Control Associations
Federation of Asian & Oceania Pest Managers Associations.
International Pest Control
Pest Management Association of New Zealand
European Commission DG Agriculture & Rural Development
Dutch Board for the Authorisation of Plant Protection Products and Biocides (CTGB)
Pest Control Association of Fiji
International Biocontrol Manufacturers’ Association
International Organisation for Biological Control
Chambre Syndicate Desinfection Desinsectisation Deratisation
Pesticide Action Network Europe
National Pest Management Association
Canadian Pest Management Association
Mexican Association of Pest Control Operators
Chilean Association of Urban Pest Controllers
Visiongain Chemicals
Visiongain Chemicals
Visiongain Chemicals
